Liver Tumor Program

  • Meet the Team

    The Liver Tumors Center is home to specialists with a wide variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for your child’s unique needs. Learn more about our faculty and staff.

  • Show All

    Medical Director

    A photo of James Geller, MD.

    James I. Geller, MD
    Medical Director, Kidney and Liver Tumors Program

    513-636-4266

    james.geller@cchmc.org

    James I. Geller, MD

    Medical Director, Kidney and Liver Tumors Program

    Co-Medical Director, Retinoblastoma Program

    Associate Director, Global Cancer Programs

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4266

    Fax: 513-636-3549

    Email: james.geller@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Developmental therapeutics; renal / liver / retinoblastoma / neuro-oncology

    Research Interests

    Elucidating ways to translate the use of biological response modifiers in combination with conventional chemotherapeutics

    Biography

    James I. Geller, MD, completed his undergraduate training at Dartmouth College, graduate medical training at the Sackler School of Medicine, residency training in pediatrics at New York Medical College and pediatric hematology / oncology training at St. Jude Children's Research Hospital. His current appointment is with the University of Cincinnati and Children's Hospital Medical Center in the capacity of associate professor of pediatrics.

    Dr. Geller's clinical and academic interests pertain to children and families affected by solid tumors, including brain tumors. Dr. Geller's expertise is recognized both nationally and internationally in the fields of retinoblastoma, renal tumors, liver tumors and brain tumors, as witnessed by his appointments to the Children's Oncology Group (COG) Rare/Retinoblastoma Committee as both a Steering/Voting Member and as liaison to the COG Young Investigator Committee; the COG Renal Tumor Committee (RTC) as Steering/Voting Member, RTC Sub-Committee Chair of Developmental Therapeutics, and RTC liaison to both the COG Developmental Therapeutics Committee and the Pediatric Preclinical Testing Program Guidance Committee; and to the Central Nervous System (Brain Tumor) Committee as a voting member. Dr. Geller has been an invited speaker at numerous national and international meetings and symposia and spearheads both local and national clinical research initiatives in these areas, with an emphasis on finding new treatment options.

    Education and Training

    MD: Sackler School of Medicine, 1997.

    Residency: New York Medical College, 2000.

    Fellowship: St Jude Children's Research Hospital, 2004.

    Certification: Pediatrics, 2000, 2007; Pediatric Hematology / Oncology, 2005.

    Publications

    View PubMed Publications

    Grants

    Identification, selection, and validation of rationale molecular targets that result from this High-Risk Wilms ‘TARGET’ initiative. National Institutes of Health. 2009 - 2011.

    Oncology

    A photo of Denise Adams.

    Denise M. Adams, MD
    Marjory J. Johnson Chair of Vascular Tumor Translational Research

    513-636-4266

    denise.adams@cchmc.org

    Denise M. Adams, MD

    Marjory J. Johnson Chair of Vascular Tumor Translational Research

    Medical Director, Comprehensive Hemangioma and Vascular Malformation Center

    Fellowship Director, Hematology / Oncology

    Professor, UC Department of Pediatrics

    Phone: 513-636-4266

    Fax: 513-636-3549

    Email: denise.adams@cchmc.org

    Show All

    Biography

    Denise Adams, MD, is fellowship director of the Hematology / Oncology Fellowship Program and medical director of the Hemangioma and Vascular Malformations Center at Cincinnati Children’s. One of the vascular team’s main priorities has been establishing standards of care for patients with these diagnoses so they can follow outcome measures. Of key interest to Dr. Adams, as an oncologist, is the improvement in care of patients with kaposiform hemangioendotheliomas (KHE). The team of experts has established a clinical registry for these patients to gain insight into the clinical characteristics of KHE patients and the long term outcomes of these patients. They also have a phase II FDA funded trial for complicated vascular anomalies and KHE patients are included in this trial. These tumors are rare but have a very high mortality and morbidity rate. It is important that the group learn more about the clinical characteristics, phenotype, biomarkers which can lead to further investigations and clinical trials.

    Education and Training

    MD: Georgetown University School of Medicine, 1988.

    Post-Graduate: Georgetown University, 1983.

    BSN: Georgetown University, 1982.

    Publications

    View PubMed Publications

    Grants

    Phase II Study of Rapamycin for Complicated Vascular Anomalies. Food and Drug Administration. Sep 2009 - Aug 2013. #R01 FD 003712.

    A photo of James Geller, MD.

    James I. Geller, MD
    Medical Director, Kidney and Liver Tumors Program

    513-636-4266

    james.geller@cchmc.org

    James I. Geller, MD

    Medical Director, Kidney and Liver Tumors Program

    Co-Medical Director, Retinoblastoma Program

    Associate Director, Global Cancer Programs

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4266

    Fax: 513-636-3549

    Email: james.geller@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Developmental therapeutics; renal / liver / retinoblastoma / neuro-oncology

    Research Interests

    Elucidating ways to translate the use of biological response modifiers in combination with conventional chemotherapeutics

    Biography

    James I. Geller, MD, completed his undergraduate training at Dartmouth College, graduate medical training at the Sackler School of Medicine, residency training in pediatrics at New York Medical College and pediatric hematology / oncology training at St. Jude Children's Research Hospital. His current appointment is with the University of Cincinnati and Children's Hospital Medical Center in the capacity of associate professor of pediatrics.

    Dr. Geller's clinical and academic interests pertain to children and families affected by solid tumors, including brain tumors. Dr. Geller's expertise is recognized both nationally and internationally in the fields of retinoblastoma, renal tumors, liver tumors and brain tumors, as witnessed by his appointments to the Children's Oncology Group (COG) Rare/Retinoblastoma Committee as both a Steering/Voting Member and as liaison to the COG Young Investigator Committee; the COG Renal Tumor Committee (RTC) as Steering/Voting Member, RTC Sub-Committee Chair of Developmental Therapeutics, and RTC liaison to both the COG Developmental Therapeutics Committee and the Pediatric Preclinical Testing Program Guidance Committee; and to the Central Nervous System (Brain Tumor) Committee as a voting member. Dr. Geller has been an invited speaker at numerous national and international meetings and symposia and spearheads both local and national clinical research initiatives in these areas, with an emphasis on finding new treatment options.

    Education and Training

    MD: Sackler School of Medicine, 1997.

    Residency: New York Medical College, 2000.

    Fellowship: St Jude Children's Research Hospital, 2004.

    Certification: Pediatrics, 2000, 2007; Pediatric Hematology / Oncology, 2005.

    Publications

    View PubMed Publications

    Grants

    Identification, selection, and validation of rationale molecular targets that result from this High-Risk Wilms ‘TARGET’ initiative. National Institutes of Health. 2009 - 2011.

    Hepatology

    A photo of John Bucuvalas.

    John C. Bucuvalas, MD
    Associate Medical Director, Pediatric Liver Care Center

    513-636-4415

    john.bucuvalas@cchmc.org

    John C. Bucuvalas, MD

    Associate Medical Director, Pediatric Liver Care Center

    Professor, UC Department of Pediatrics

    Phone: 513-636-4415

    Fax: 513-636-7805

    Email: john.bucuvalas@cchmc.org

    Show All

    Specialties

    Liver disease; transplantation; outcomes research; improving the quality of health care delivery.

    Visit the Bucuvalas Lab.

    Biography

    John Bucuvalas, MD, came to Cincinnati Children's Hospital Medical Center in 1982 as a fellow in gastroenterology. He joined the faculty in 1986. He graduated from Harvard College in 1974 and Harvard Medical School in 1978. He completed a pediatric residency at Massachusetts General Hospital and served there as Chief Resident from 1981 to 1982.

    Over the last 10 years, the focus his patient care and research efforts have been outcomes research and improving the care delivery system for children with chronic liver disease who then may undergo liver transplantation. He has focused on integration of research into patient care and improving the care delivery system. Along the way, he has gained significant content knowledge through traditional research but additionally have learned how to improve processes, understand the system that is academic medicine, interpret variation and recognize the role of leadership both for research and clinical efforts. Dr. Bucuvalas has made significant contributions in the clinical and research arenas towards improving care, enhancing the delivery care and optimizing the outcome of children with chronic liver disease and pediatric liver transplant recipients.

    Dr. Bucuvalas has been recognized as a leader in the field of pediatric hepatology and liver transplantation at a local, regional and national level.

    Education and Training

    AB: Harvard College, Cambridge, MA, 1974.

    MD: Harvard Medical School, Boston, MA, 1978.

    Residency: Pediatrics, Massachusetts General Hospital, Boston, MA, 1978 to 1981.

    Chief Residency: Pediatrics, Massachusetts General Hospital, Boston, MA, 1981 to 1982.

    Fellowship: Gastroenterology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 1982 to 85.

    Research Scholar: Gastroenterology, Children's Hospital Research Foundation, Cincinnati, OH, 1985 to 86.

    Certification: Pediatrics, 1983; Pediatric Gastroenterology, 1990; recertified, 1997, 2004.

    Publications

    View PubMed Publications

    Kathleen M. Campbell, MD

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4415

    Fax: 513-636-7805

    Email: kathleen.campbell@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Diagnosis and management of pediatric liver disease, particularly biliary atresia and other forms of neonatal cholestasis; liver transplantation and post-transplant renal dysfunction.

    Research Interests

    Clinical and genetic determinants of calcineurin inhibitor induced post-transplant nephrotoxicity; disease modifiers in biliary atresia

    Biography

    Kathleen M. Campbell, MD, joined the Division of Gastroenterology, Hepatology and Nutrition as a fellow in 2000, after completing her Pediatric Residency Training at Cincinnati Children's Hospital Medical Center. Following the completion of her fellowship, she pursued an additional year of training in Pediatric Hepatology under the mentoring of Dr. William Balistreri and the physicians and surgeons of the Pediatric Liver Care Center, becoming one of the first in her specialty to obtain focused training in this field.

    In 2004, Dr. Campbell was appointed Assistant Professor of Pediatrics in the Division of Gastroenterology, Hepatology and Nutrition and the Pediatric Liver Care Center. Her clinical and translational research interests include post-transplant renal dysfunction and genetic modifiers of disease in biliary atresia.

    Education and Training

    MD: University of Tennessee College of Medicine, Memphis, TN, 1997.

    Residency: Pediatrics, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2000.

    Fellowship: Pediatric Gastroenterology, Hepatology and Nutrition, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2003.

    Advanced Fellowship: Pediatric Hepatology, University of Cincinnati and Cincinnati Children's Hospital Medical Center, 2004.

    Certification: Pediatrics, 2000; Pediatric Gastroenterology, Hepatology and Nutrition, 2003.

    Publications

    View PubMed Publications

    A photo of Rohit Kohli.

    Rohit Kohli, MBBS, MS
    Associate Medical Director, Liver Transplant Program

    513-636-8948

    rohit.kohli@cchmc.org

    Rohit Kohli, MBBS, MS

    Associate Medical Director, Liver Transplant Program

    Co-Director, Steatohepatitis Center

    Attending Physician, Liver Care Center

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-8948

    Fax: 513-636-5581

    Email: rohit.kohli@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Non-alcoholic steatohepatitis; liver transplantation; mitochondrial hepatopathies

    Research Interests

    Obesity related fatty liver disease (non-alcoholic steatohepatitis)

    Visit the Kohli Lab

    Biography

    Rohit Kohli, MBBS, MS, is currently an associate professor of Pediatrics at the University of Cincinnati, College of Medicine and the co-director of the Cincinnati Children's Steatohepatitis Center.

    Dr. Kohli received his medical degree from the Armed Forces Medical College, India in 1999 and his MS in Clinical Investigation from Northwestern University in 2006. While at Northwestern he first spent three years as a Pediatric Gastroenterology and Hepatology fellow and then subsequently as a Transplant Hepatology trainee before relocating to the University of Cincinnati in 2007.

    His research work has focused on the pathogenesis of obesity related fatty liver disease (NAFLD). In particular, he has focused upon the role of reactive oxygen stress in the generation and regulation of the extreme stage of this disease; nonalcoholic steatohepatitis (NASH). Dr. Kohli's laboratory currently focuses on the role of fructose in triggering above mentioned oxidative injury and fibrosis within the liver. He also works with Drs. Randy Seeley and Stephen Woods at the Metabolic Diseases Institute at the University of Cincinnati to understand the mechanism and impact of bariatric surgical procedures on NASH and other co-morbidities of obesity.

    He has published many peer-reviewed articles including articles in The Journal of Biological Chemistry, Hepatology, Journal of Pediatrics, and The American Journal of Physiology. He is the author of many book chapters and review articles. He also is the recipient of the 2007 George Ferry Young Investigator Award from the Children's Digestive Health and Nutrition Foundation and a Fellowship award from the American Association for the Study of Liver Diseases. His clinical efforts are focused within the Steatohepatitis Center and Liver Care Center at the Division of Gastroenterology, Hepatology, and Nutrition at Cincinnati Children's Hospital Medical Center.

    Education and Training

    MS: Clinical Investigation, School of Public Health, Northwestern University, IL, 2004-2006.

    MBBS: Armed Forces Medical College, Pune University, India,1993-1999.

    Residency: Metropolitan Hospital, New York Medical College, NY, 2000-2003.

    Fellowship: Gastroenterology, Children's Memorial Hospital, Northwestern University, IL, 2003-2006.

    Fellowship: Transplant Hepatology, Children's Memorial Hospital, Northwestern University, IL, 2006-2007.

    Certification: Pediatrics, 2004; Transplant Hepatology, 2010; Gastroenterology, 2009.

    Publications

    View PubMed Publications

    Grants

    Role of Ileum in Reducing Obesity Related Comorbidities. Principal Investigator. National Institutes of Health. Sep 2009 - Aug 2013. #1K08DK084310.

    Ethicon Enhanced Assay Development. Co-investigator. University of Cincinnati. Jan 2009 - Jan 2014.

    Clinical Research Network in Non-Alcoholic Steatohepatitis (NASH CRN). Co-investigator. National Institutes of Health. Aug 2009 - Apr 2014. #U01DK061732.

    Mike A. Leonis, MD, PhD

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4415

    Fax: 513-636-7805

    Email: mike.leonis@cchmc.org

    Show All

    Specialties

    Pediatric hepatology, especially acute liver failure; inflammatory disease processes of the liver; hepatoblastoma; mechanisms of hepatic tumor formation

    Education and Training

    MD: Washington University School of Medicine, St. Louis, MO, 1996.

    PhD: Washington University School of Medicine, St. Louis, MO, 1996.

    Procter Scholar: Cincinnati Children's Hospital Medical Center, 2002-2005.

    Fellowship: Cincinnati Children's, 1999-2002.

    Residency: Primary Children's Hospital Medical Center, University of Utah School of Medicine, Salt Lake City, UT, 1996-1999.

    Certification: American Board of Pediatrics, 1999; Pediatric Gastroenterology, Hepatology and Nutrition, 2003.

    Publications

    View PubMed Publications

    Liver Transplantation Surgery

    A photo of Maria Alonso-Peclet, MD.

    Maria H. Alonso-Peclet, MD
    Surgical Director, Kidney Transplant Program

    513-636-4371

    maria.alonso@cchmc.org

    Maria H. Alonso-Peclet, MD

    Surgical Director, Kidney Transplant Program

    Co-Surgical Director, Intestinal Transplant Surgery

    Associate Professor, UC Department of Surgery

    Phone: 513-636-4371

    Fax: 513-636-7657

    Email: maria.alonso@cchmc.org

    Show All

    Specialties

    Liver, kidney transplantation; hepatobiliary surgery; minimally invasive surgery; trauma 

    Education and Training

    MD: University of Pennsylvania School of Medicine, Philadelphia, PA, 1982.

    Residency: Surgery, Eastern Virginia Graduate School of Medicine, Norfolk, VA.

    Fellowship: Trauma / Critical Care, Maryland Institute for Emergency Medical Services Systems, Baltimore, MD; Trauma / Burn, Children's National Medical Center, Washington, D.C.; Pediatric Surgery, Children's Mercy Hospital, Kansas City, MO; Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH.

    Certification: Surgery, 1999; Pediatric Surgery, 2001; Surgical Critical Care, 2001.

    A photo of Jaimie Nathan, MD.

    Jaimie D. Nathan, MD
    Surgical Director, Intestinal Transplant Program

    513-636-4371

    jaimie.nathan@cchmc.org

    Jaimie D. Nathan, MD

    Surgical Director, Intestinal Transplant Program

    Assistant Professor, UC Department of Surgery

    Phone: 513-636-4371

    Fax: 513-636-7657

    Email: jaimie.nathan@cchmc.org

    Show All

    Specialties

    Hepatobiliary and pancreatic disease; liver, kidney, and intestinal transplantation; pediatric surgical oncology; neonatal surgery; minimally invasive surgery

    Education and Training

    BS: Yale University, New Haven, CT, 1993.

    MD: Yale University, New Haven, CT, 1998.

    Residency: General Surgery, Duke University Medical Center, Durham, NC, 1998-2000 and 2002-2005.

    Surgical Research Fellowship: Duke University Medical Center, Durham, NC, 2000-2002.

    Pediatric Surgery Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2005-2007.

    Transplant Surgery Fellowship: University of Cincinnati, Cincinnati, OH, 2007-2009.

    Certification: American Board of Surgery, General Surgery, 2007; American Board of Surgery, Pediatric Surgery, 2008; American Society of Transplant Surgeons Certification, 2009.

    Publications

    View PubMed Publications

    A photo of Frederick Ryckman, MD.

    Frederick C. Ryckman, MD
    Professor of Surgery / Transplantation

    513-636-4371

    frederick.ryckman@cchmc.org

    Frederick C. Ryckman, MD

    Professor of Surgery / Transplantation

    Sr. Vice President, Medical Operations

    Professor, UC Department of Surgery

    Phone: 513-636-4371

    Fax: 513-636-7657

    Email: frederick.ryckman@cchmc.org

    Show All

    Specialties

    Transplantation; liver; kidney transplantation; small intestine; biliary disease; Extracorporeal membrane oxygenation (ECMO); minimally invasive surgery; chest wall abnormalities

    Biography

    Frederick C. Ryckman, MD, is clinical director of the Pediatric General and Thoracic Surgery Division.

    Dr. Ryckman is also vice president of System Capacity & Perioperative Operations.

    Dr. Ryckman is also a pediatric surgeon at the Cincinnati Fetal Center.

    Education and Training

    BS: Lyman Briggs College of Science and Mathematics, Michigan State University, East Lansing, MI, 1969 to 1973.

    MD: University of Michigan Medical School, Ann Arbor, MI, 1977.

    Residency: University of Florida Medical Center, Gainesville, FL, 1977 to 1982.

    Fellowship: Pediatric Surgery, Children's Hospital Medical Center, Cincinnati, OH, 1982 to 1984.

    Certification: National Board of Medical Examiners, 1977; American Board of Surgery, 1983; recertification, 1993; Certificate of Special Competence in Pediatric Surgery, 1986; recertification, 1993.

    Publications

    View PubMed Publications
    A photo of Gregory Tiao.

    Greg M. Tiao, MD
    Richard and Geralyn Azizkhan Chair in Pediatric Surgery

    513-636-4371

    greg.tiao@cchmc.org

    Greg M. Tiao, MD

    Richard and Geralyn Azizkhan Chair in Pediatric Surgery

    Surgical Director, Liver Transplantation

    Associate Director, Pediatric Surgery Fellowship

    Associate Professor, UC Department of Surgery

    UC Department of Pediatrics

    Phone: 513-636-4371

    Fax: 513-636-7657

    Email: greg.tiao@cchmc.org

    Show All

    Specialties

    Biliary atresia

    Biography

    As a pediatric surgeon and a transplant surgeon, Dr. Tiao is involved in the care of children afflicted with biliary atresia from the time of presentation and diagnosis to the initial Kasai portoenterostomy to the liver transplant, when necessary. He sees the many challenges children and their families experience when diagnosed with this life threatening disease process. From that perspective, defining the basis of this disease process such that therapeutic strategies can be developed eliminating these complex interventions is his career goal. His short term goal is to develop an independent research laboratory investigating the pathogenesis of virus induced biliary atresia specifically seeking to determine the mechanistic basis of this disease so that new treatment strategies can be developed to salvage the native liver. 

    Dr. Tiao's  overarching hypothesis is that biliary atresia results from the infection of cholangiocytes by a virus triggering immune-mediated biliary obstruction. His focus is to determine the mechanisms used by RRV to infect cholangiocytes, how RRV undergoes replication within the cholangiocyte, and how infected cholangiocytes modify the microenvironment, activating the immune system resulting in biliary obstruction. Determination of the mechanistic basis of these inter-related events is essential to understanding the pathogenesis of virus induced BA. By focusing on the basis for the viral insult in the initiation of biliary atresia, he has defined an area of independence from Dr Jorge Bezerra, his primary research mentor. 

    Education and Training

    BS: Northwestern University, Evanston, IL, 1986.

    MD: University of Illinois, Chicago, IL, 1990.

    Residency: Loyola University, Maywood, IL, 1991-1992; Senior Resident, Department of Surgery, University of Cincinnati, Cincinnati, OH, 1995-1997;Chief Resident, Department of Surgery, University of Cincinnati, Cincinnati, OH, 1997-1998.

    Fellowships: Research Fellow, University of Cincinnati, Cincinnati, OH, 1992-1995; Transplant Surgery Fellow, University of Cincinnati, Cincinnati, OH, 2000-2002;Pediatric Surgery Fellow, Los Angeles Children's Hospital, Los Angeles, CA, 1998-2000.

    Certification: Pediatric Surgeon, 2000; Transplant Surgeon, 2002.

    Publications

    Grants

    The Molecular Determinants of Virus Induced Biliary Induced Biliary Asteria. Principal Investigator. Apr 2011 - Mar 2016.

    Nycomed Liver Trial. Principal Investigator. 2012 - present. TC-2402-040-SP.


    Pathology

    Kevin E. Bove, MD

    Professor, UC Department of Pediatrics

    UC Department of Pathology & Laboratory Medicine

    Phone: 513-636-4261

    Fax: 513-636-3924

    Email: kevin.bove@uc.edu

    Show All

    Specialties

    Research Interests

    Dr. Bove's current research focus is on pathogenesis of biliary atresia and other cholestatic disorders of infancy. He has long term research interests in the early stages of childhood neoplasia and childhood diseases of skeletal muscle and heart.

    Clinical Interests

    Dr. Bove has been a career academic pediatric pathologist at Cincinnati Children's since 1968. He functions as a surgical pathologist, autopsy consultant and electron microscopist with diverse clinical interests. His collaborations with faculty and fellows in many divisions have resulted in more than 180 peer-reviewed and more than 120 publications.

    Biography

    Kevin E. Bove, MD, has 32 years experience as a pediatric pathologist at Cincinnati Children's Hospital Medical Center.

    Dr. Bove has achieved national recognition as an expert in tumors; neuromuscular diseases; liver diseases of children and performance / interpretation of pediatric autopsies.

    Dr. Bove has and continues to be involved in leadership positions in the Society for Pediatric Pathology and the College of American Pathologists.

    Education and Training

    MD: State University of New York, Buffalo, NY.

    Residency: Rotating Intern, Cincinnati General Hospital, 1961-1962; Pathology, Cincinnati General Hospital, 1962-1966.

    Certification: American Board of Pathology in Anatomic and Clinical Pathology, 1967 and 1968; Pediatric Pathology, 1990.

    Radiology

    A photo of Manish Patel, DO.

    Manish N. Patel, DO
    Interventional Radiologist, Department of Radiology

    513-636-6695

    manish.patel@cchmc.org

    Manish N. Patel, DO

    Interventional Radiologist, Department of Radiology

    Assistant Professor, UC Department of Radiology

    Phone: 513-636-6695

    Fax: 513-636-1388

    Email: manish.patel@cchmc.org

    Show All

    Biography

    Manish Patel, DO, has helped to expand the treatment options for high flow vascular malformation. He works as director of daily operation in IR and as the associate fellowship director of the pediatric radiology fellowship program.

    Education and Training

    DO: University of Health Sciences - College of Osteopathic Medicine, Kansas City, MO, 1999.

    Internship: Metropolitan Hospital, Grand Rapids, MI.

    Residency: University of Missouri-Kansas City, Kansas City, MO.

    Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    Certification: American Board of Radiology and American Osteopathic Board of Radiology, 2004.

    Publications

    View PubMed Publications
    A photo of John Racadio.

    John M. Racadio, MD
    Division Chief, Interventional Radiology, Department of Radiology

    513-636-3385

    john.racadio@cchmc.org

    John M. Racadio, MD

    Division Chief, Interventional Radiology, Department of Radiology

    Interventional Radiologist

    Professor, UC Department of Radiology

    Phone: 513-636-3385

    Fax: 513-636-4208

    Email: john.racadio@cchmc.org

    Show All

    Specialties

    Vascular access; gastrointestinal interventional radiology

    Biography

    John Racadio, MD, has been practicing interventional radiology (IR) for 14 years and has been the division chief of interventional radiology at Cincinnati Children’s Hospital Medical Center for the past 11 years. He has expertise in performing a wide range of vascular procedures including angiography, angioplasty, embolization, vascular access, and thrombolysis in patients ranging from 500g to 150kg.

    He is also the director of the interventional radiology research lab, which is part of the Department of Radiology Imaging Research Center (IRC). This state-of-the-art IR lab, which is identical to our clinical IR labs, possesses cutting edge digital flat detector technology including 3-D rotational angiography (3DRA), 3-D Roadmapping, and C-arm cone beam CT. These features provide superior image quality for digital subtraction angiography, 3-D angiography reconstruction, and “CT-like” imaging. Lab support staff includes RT(R) licensed IR technologists, and an IR lab manager. The long term goal of the IR research lab is to develop new image guided interventional procedures and imaging techniques and protocols to improve clinical outcomes. Having an IR research lab identical to our IR clinical labs facilitates translation of lab results into clinical practice.

    Education and Training

    BS: Stanford University, Palo Alto, CA, 1987.

    MD: University of Cincinnati, Cincinnati, OH, 1992.

    Residency: University of Cincinnati, Cincinnati, OH, 1993-1997.

    Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 1997-1998.

    Certification: Certificate of Added Qualifications, Pediatric Radiology, November 2001; Diagnostic Radiology, American Board of Radiology, 1997.

    Publications

    View PubMed Publications

    A photo of Alexander Towbin.

    Alexander J. Towbin, MD
    Radiologist, Department of Radiology

    513-636-5896

    alexander.towbin@cchmc.org

    Alexander J. Towbin, MD

    Radiologist, Department of Radiology

    Neil D. Johnson Chair, Radiology Informatics

    Co-Chief, Thoracoabdominal Imaging

    Assistant Professor, UC Department of Radiology

    Phone: 513-636-5896

    Fax: 513-803-3015

    Email: alexander.towbin@cchmc.org

    Show All

    Specialties

    Radiology informatics; cancer imaging; abdominal imaging

    Education and Training

    MD: Doctor of Medicine, University of Cincinnati, 2002.

    Internship: Pediatrics, Cincinnati Children’s Hospital Medical Center-University of Cincinnati College of Medicine, 2002-2003.

    Residency: Diagnostic Radiology, University of Pittsburgh Medical Center, 2003-2007.

    Fellowship: Pediatric Radiology, Cincinnati Children’s Hospital Medical Center-University of Cincinnati College of Medicine, 2008.

    Certification: American Board of Radiology, 2007.

    Publications

    View PubMed Publications